Walleye Trading
MYOV

Walleye Trading’s Myovant Sciences Ltd. MYOV Stock Holding History

Walleye Trading’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,100
Closed -$167K – 5669
2021
Q1 		$167K Buy
8,100
+7,700
+1,925% +$175K ﹤0.01% 3779
2020
Q4 		$11K Buy
+400
New +$7.79K ﹤0.01% 4444

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Walleye Trading's MYOV Position: Q2 2021 in Review

Walleye Trading sold out of Myovant Sciences Ltd. (MYOV) in Q2 2021, closing a stake of 2,048 shares — an estimated $42K sold.

Walleye Trading first reported a position in MYOV in Q4 2020 and held it in 2 quarters. The position peaked at $577K in Q4 2020. 108 funds tracked by Wall St. Rank hold MYOV as of Q2 2021.

  • Walleye Trading reported no remaining Myovant Sciences Ltd. position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 2,048 Myovant Sciences Ltd. shares in Q2 2021, an estimated $42K.
  • Walleye Trading first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 2 quarters.
  • Walleye Trading's Myovant Sciences Ltd. position peaked at $577K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.